Bio-Rad Laboratories (BIO) Q1 2025 Earnings
Bio-Rad Laboratories reported Q1 2025 revenue of $585.4M (-4.2% YoY), beat analyst consensus of $573.2M by $12.2M. Diluted EPS came in at $2.54 (+10.9% YoY), beat the $1.73 consensus by $0.81.
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Bio-Rad Laboratories's Q1 2025 earnings report.
Bio-Rad Laboratories (BIO) reported Q1 2025 earnings on May 1, 2025 after market close.
Bio-Rad Laboratories reported revenue of $585.4M and diluted EPS of $2.54 for Q1 2025.
Revenue beat the consensus estimate of $573.2M by $12.2M. EPS beat the consensus estimate of $1.73 by $0.81.
Compared to the same quarter a year prior, revenue declined 4.2% from $610.8M a year earlier and diluted EPS grew 10.9% from $2.29.
You can read the 10-Q periodic report (0000012208-25-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.